Eisai Korea Inc.
Eisai Korea Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants | Digestive System Diseases, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, colitis, colonic disorder, connective tissue disorder, digestive system disorder, gastroenteritis, immune system disorder, inflammatory bowel disease, intestinal disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, ulcerative colitis | Recruiting | Not stated | 2026-07-06 | NCT06246123 | |
| A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Active, not recruiting | Phase 4 | 2026-07-02 | NCT06964113 | |
| A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Not stated | 2026-04-21 | NCT06810960 |